Professor Pam Kearns

Cutting edge clinical trials

Professor Pam Kearns is Director of the Cancer Research UK Clinical Trials Unit (CRCTU) at the University of Birmingham. This unit is the biggest of its kind in the UK and has been translating cutting-edge science into better care for cancer patients for over 20 years.

Many clinical trials designed and conducted at the CRCTU, particularly for children’s cancer and rare cancers, are collaborative international efforts, bringing together cancer researchers across the world. Other trials are smaller and more experimental, pioneering ground-breaking new cancer therapies.

And in recognition of the need for therapies tailored to the individual patient, the Unit is delivering trials looking into personalised cancer medicine, which aims to make treatment more focused to the individual, more effective and with fewer side effects.

Big clinical trials units like the CRCTU have a huge part to play in helping us beat cancer sooner, by helping to turn research in the lab into real treatments that save lives.

You can see Professor Kearns talk about her work on childhood cancer here


All cancer types
Clinical trials

Cancer Research UK Clinical Trials Unit, The University of Birmingham, Birmingham